- Home
- XAIR vs LUMO Comparison
XAIR vs LUMO Comparison
Compare XAIR & LUMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- LUMO
- Stock Information
- Founded
- XAIR 2011
- LUMO 2011
- Country
- XAIR United States
- LUMO United States
- Employees
- XAIR N/A
- LUMO N/A
- Industry
- XAIR Medical/Dental Instruments
- LUMO Biotechnology: Pharmaceutical Preparations
- Sector
- XAIR Health Care
- LUMO Health Care
- Exchange
- XAIR Nasdaq
- LUMO Nasdaq
- Market Cap
- XAIR 34.7M
- LUMO 37.7M
- IPO Year
- XAIR N/A
- LUMO N/A
- Fundamental
- Price
- XAIR $0.50
- LUMO $4.33
- Analyst Decision
- XAIR Strong Buy
- LUMO Buy
- Analyst Count
- XAIR 4
- LUMO 4
- Target Price
- XAIR $3.67
- LUMO $9.38
- AVG Volume (30 Days)
- XAIR 636.5K
- LUMO 130.8K
- Earning Date
- XAIR 11-11-2024
- LUMO 11-07-2024
- Dividend Yield
- XAIR N/A
- LUMO N/A
- EPS Growth
- XAIR N/A
- LUMO N/A
- EPS
- XAIR N/A
- LUMO N/A
- Revenue
- XAIR $2,342,000.00
- LUMO $2,205,000.00
- Revenue This Year
- XAIR $640.47
- LUMO $184.11
- Revenue Next Year
- XAIR $286.81
- LUMO N/A
- P/E Ratio
- XAIR N/A
- LUMO N/A
- Revenue Growth
- XAIR 685.91
- LUMO 300.59
- 52 Week Low
- XAIR $0.30
- LUMO $1.37
- 52 Week High
- XAIR $2.36
- LUMO $4.58
- Technical
- Relative Strength Index (RSI)
- XAIR 56.04
- LUMO 56.58
- Support Level
- XAIR $0.42
- LUMO $4.25
- Resistance Level
- XAIR $0.56
- LUMO $4.44
- Average True Range (ATR)
- XAIR 0.07
- LUMO 0.11
- MACD
- XAIR 0.00
- LUMO -0.03
- Stochastic Oscillator
- XAIR 47.32
- LUMO 33.33
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.